Pink Petals Publications
“Pills, Profits, and Problems: An Anatomy of India’s Pharmaceutical Crisis”
“Pills, Profits, and Problems: An Anatomy of India’s Pharmaceutical Crisis”

Type: Open Access Book
Title: “Pills, Profits, and Problems: An Anatomy of India’s Pharmaceutical Crisis”
Author Name - Dr. Rajesh Ranjan (Editor), Dr. Pulkit Khanna (Co-Editor)
ISBN: 978-93-94156-97-5
ISBN 93-94156-97-6
DOI: 
Language: English
Published by Pink Petals Publication Pvt Ltd.
© 2025 This work is licensed under the Creative Commons Attribution 4.0 (CC-BY 4.0). It permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/

Digital Object Identifiers - 

Book

3-4
Contents
PDF
5-6
List of Contributors
PDF
9
Preface
PDF
10
Part 1 Manufacturers – The Pill Factories and the Profit Motive
PDF
11-16
Chapter 1 The Making of India’s Pharma Powerhouse
PDF
17-23
Chapter 2 Quality Control or Chaos?
PDF
24-30
Chapter 3 The Broken Chain of R&D
PDF
31-37
Chapter 4 Pricing Wars and Policy Evasion
PDF
38-44
Chapter 5 Marketing Malpractices and Unethical Promotions
PDF
45
Part 2 Doctors – Prescriptions, Power, and Perks
PDF
46-51
Chapter 6 The Branded Prescription Problem
PDF
52-57
Chapter 7 The Pharma–Doctor Nexus
PDF
58-64
Chapter 8 Prescription Practices in the Grey
PDF
65-70
Chapter 9 Accountability and Continuing Education
PDF
71
Part III Patients – The End-Users in the Blind Spot
PDF
72-77
Chapter 10 The Cost Burden – When Illness Becomes Debt
PDF
78-83
Chapter 11 Health Illiteracy and Blind Trust
PDF
84-89
Chapter 12 Drug Availability and Stockouts
PDF
90-95
Chapter 13 Adverse Drug Reactions and the Silence of Reporting
PDF
96
Part IV Chemists – Gatekeepers or Middlemen?
PDF
97-102
Chapter 14 Unlicensed Stores and Unethical Dispensing
PDF
103-108
Chapter 15 Selling Without Prescription – A Grey Market of Medicines
PDF
109-113
Chapter 16 Online Pharmacies – Disruption or Danger?
PDF
114-118
Chapter 17 The Challenge of Generic Substitution – Margin Wars and Confusion at the Counter
PDF
119
Part 5 Reforms and the Road Ahead
PDF
120-124
Chapter 18 The Policy Vacuum – Fragmented Governance in India’s Pharma Sector
PDF
125-130
Chapter 19 Strengthening the Regulators – CDSCO, NPPA, and State FDAs
PDF
131-136
Chapter 20 Transparency, Technology, and the Way Forward
PDF
1-136
FULL PDF
PDF
Download the Cover
PDF